Sridhar G. Prasad serves as Executive at Drugs Made In America Acquisition II Corp., where they oversee executive responsibilities. Since joining the company, Sridhar G. Prasad has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 26, 2025 involved transacting 100,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Sep 26, 2025 | DMII | $0 | Other | 100,000 | $N/A | Discretionary |
Sridhar G. Prasad currently holds 100,000 shares of Drugs Made In America Acquisition II Corp. (DMII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sridhar G. Prasad has been a net neutral trader of DMII stock. They have purchased $0 and sold $0 worth of shares.
Sridhar G. Prasad's most recent insider trade was on Sep 26, 2025, when they sold 100,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted